Press releases


News from the world of VisionHealth

VisionHealth GmbH closes growth financing round

New investors validate the enormous potential for VisionHealth and Kata®

Read More


0 Comments3 Minutes

VisionHealth receives grant from European Commission

The Munich based start-up VisionHealth received a grant with the renowned SME funding from the EU's Horizon 2020 research and innovation program. The pioneer in digital therapy supports patients with chronic respiratory diseases (CRD).

Read More


0 Comments1 Minutes

Now in app stores

Kata® puts an end to inefficient inhalation therapy: The start of the first purely digital therapy support for chronic respiratory diseases

Read More


0 Comments5 Minutes

Philipp Kroneberg becomes second managing director

VisionHealth GmbH strengthens with Mr. Philipp Kroneberg as second managing director. In addition to founder Dr. Sabine Häußermann, the start-up will thus have an effective and competent dual leadership from November 2018. Mr. Kroneberg has many years of global professional experience in the fields of business development and portfolio management in respiratory medicine and is very experienced in the field of telemedicine.

Read More


0 Comments3 Minutes

How much potential lies in digital health?

New technologies are conquering the healthcare sector and providing an additional growth boost for the industry. Venture capitalists have invested billions of dollars in private digital health companies in recent years. Stefan Blum and Marcel Fritsch, portfolio managers of the Swiss Bellvue Group, an asset manager specialising in the healthcare sector, therefore expect a wave of IPOs from this young segment of the healthcare market.

Read More


0 Comments5 Minutes

Unknown killer COPD

Chronic obstructive pulmonary disease (COPD) can be life-threatening. By 2030, it will be the third leading cause of death. Nevertheless, the term COPD is unknown to a large majority of Germans. The key in the fight against COPD is adherence to therapy. Kata®, the app of the Munich-based start-up VisionHealth (https://visionhealth.gmbh), is now intended to help those affected with treatment adherence and efficiency, while reducing the costs of chronic lung diseases, which amount to 82.3 billion euros annually in the EU alone.

Read More


0 Comments6 Minutes